-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

Benzinga·05/26/2026 17:15:19
Listen to the news
Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.